You have no items in your shopping cart.
Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [6G9]
Description
Images & Validation
−| Tested Applications | ELISA |
|---|---|
| Reactivity | Virus |
| Application Notes |
Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Host | Human |
| Clonality | Recombinant |
| Isotype | Human IgG1 |
| Clone No. | 6G9 |
| Immunogen | full length recombinant Nucleocapsid Protein |
| Target | N |
| Purification | ≥95 % |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| Form/Appearance | Liquid |
| Buffer/Preservatives | PBS, pH 7.4 |
| Concentration | 5.0 mg/ml (+/- 10 %) |
| Disclaimer | For research use only |
Alternative Names
−
Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
![Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [6G9]](/images/pub/media/catalog/product/NewWebsite/15/orb1274615_1.jpg)
Immobilized 2019-nCoV Nucleocapsid Protein (Cat#orb1228242) at 5.0μg/ml (100μL/well) can bind 2019-nCoV NP Antibody (6G9), the EC50 for this effect is 5-30ng/ml.
![Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [6G9]](/images/pub/media/catalog/product/NewWebsite/15/orb1274615_2.jpg)
Loaded 2019-nCoV Nucleocapsid Protein-His (Cat#orb1228242) on HIS1K Biosensor, can bind 2019-nCoV NP Antibody (6G9) (Cat#orb1274615) with an affinity constant of 1.15 nM as determined in BLI assay.
![Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [6G9]](/images/pub/media/catalog/product/NewWebsite/15/orb1274615_3.jpg)
Please note that pair recommendations are based on results obtained by our laboratory. Equally good results may be obtained using other pairs and therefore these recommendations are only indicative.
![Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [6G9]](/images/pub/media/catalog/product/NewWebsite/15/orb1274615_4.jpg)
Freeze-thaw stability is tested by repeated freeze-thaw cycles. The result showed that product bioactivity is no significant differences after freeze-thawing 10 times.
![Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [6G9]](/images/pub/media/catalog/product/NewWebsite/15/orb1274615_5.jpg)
Stability is confirmed by binding ability with 2019-nCoV Nucleocapsid Protein (Cat#orb1228242). The result showed that product bioactivity is no significant differences among these samples.
Documents Download
Request a Document
Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [6G9] (orb1274615)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review